The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Cabell Christopher since 2020.
The trader's CIK number is 1814928.
At the time of the last reporting, Cabell Christopher was the EVP, Head of R&D, and CMO of Arena Pharmaceuticals Inc. (stock ticker symbol ARNA).
Also see all insider trading activities at Arena Pharmaceuticals Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2020 | ARNA | 0 | $0 | 13,000 | $884,000 | 15,500 | $341,640 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2020-11-25 | ARNA | Option Ex | 2,500 | .00 | 0 |
| 2020-07-15 | ARNA | Sale | 13,000 | 68.00 | 884,000 |
| 2020-07-15 | ARNA | Option Ex | 13,000 | 26.28 | 341,640 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Cabell Christopher (EVP, Head of R&D, and CMO of Arena Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.